Medigoxin
From Wikipedia, the free encyclopedia
 |
|
|
Medigoxin
|
|
| Systematic (IUPAC) name | |
| 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-12,14- Dihydroxy-3- [(2R,4S,5S,6R)-4-hydroxy- 5-[(2S,4S,5S,6R)-4-hydroxy- 5-[(2S,4S,5S,6R)-4-hydroxy- 5-methoxy-6-methyl-oxan-2-yl]oxy- 6-methyl-oxan-2-yl]oxy-6-methyl- oxan-2-yl]oxy-10,13-dimethyl- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthren- 17-yl]-5H-furan-2-one |
|
| Identifiers | |
| CAS number | |
| ATC code | C01 |
| PubChem | |
| Chemical data | |
| Formula | C42H66O14 |
| Mol. mass | 794.965 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Medigoxin (or metildigoxin) is a cardiac glycoside closely related to digoxin.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||
